Marc D. Piroth

Assessment of Treatment Response in Patients with Glioblastoma Using <i>O</i>-(2-¹⁸F-Fluoroethyl)-l-Tyrosine PET in Comparison to MRI

Norbert Galldiks, Karl‐Josef Langen, Richard Holý et al. · Journal of Nuclear Medicine · 2012 · 201 citations · Full text

Role of <i>O</i>-(2-¹⁸F-Fluoroethyl)-l-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis

Norbert Galldiks, Gabriele Stoffels, Marc D. Piroth et al. · Journal of Nuclear Medicine · 2012 · 183 citations · Full text

Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial

Ursula Nestle, Tanja Schimek‐Jasch, Stephanie Kremp et al. · The Lancet Oncology · 2020 · 169 citations

Engineering, Oncologic Imaging, Medical Imaging +9

Prognostic Value of Early [18F]Fluoroethyltyrosine Positron Emission Tomography After Radiochemotherapy in Glioblastoma Multiforme

Marc D. Piroth, Michael Pinkawa, Richard Holý et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 148 citations

Positron Emission Tomography, Neuro-oncology, Glioma +13

Stereotactic Body Radiation Therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer

Richard Holý, Marc D. Piroth, Michael Pinkawa et al. · Strahlentherapie und Onkologie · 2011 · 126 citations

Radiation Therapy, Medicine, Cancer Treatment +6